Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Bad
|
New words:
abiraterone, absent, acuminate, adjourned, advantage, advice, Ahead, AIN, alpha, anal, anogenital, anticompetitive, antiviral, Aon, Appendix, array, atherosclerotic, autoimmune, Aybintio, background, Bank, BARDA, baseline, belonging, belzutifan, Bio, Biomedical, biometric, Bioscience, bound, BRCAm, BRUN, burden, capecitabine, career, ccRCC, CECH, Centene, center, checkpoint, childcare, CHRISTINE, clear, colon, compensatory, concierge, concurrent, condyloma, conference, confident, consecutive, consent, contemporary, Council, counter, CRAIG, creatinine, culture, curative, curatively, CV, cyclosporine, dampening, Dean, debilitating, distancing, dMMR, dosage, duly, Dunboyne, easy, emotional, empowerment, England, enjoy, enzalutamide, epidemic, erected, ESCC, estrogen, ethnically, EUA, excel, excellence, exhibit, feedback, fifty, FIGO, Finland, Flavor, Fortune, foster, fostering, futility, GDPR, gemcitabine, gender, genetic, genetical, genital, Glasgow, glioblastoma, globe, GLOCER, graft, GU, Guaranty, harbor, hereto, Hewitt, hired, hiring, home, HRD, Humana, hygiene, IASLC, IAVI, IMPOWER, Indenture, inferior, INGE, injunction, Inline, inspire, interactive, interplay, intraepithelial, ipilimumab, ITT, Journal, JPN, KATHY, knowledge, Koselugo, ladiratuzumab, lag, LEAP, LESLIE, Li, licensure, Linkbase, lufenuron, MACE, Melinda, mental, MFN, microchip, Microspherix, milbemycin, Minnesota, molnupiravir, Morgan, Mother, motivate, Native, NCI, neoplasia, neurological, Nexplanon, nonfatal, nonmetastatic, nonprofit, notably, NR, NRDL, nutrition, ODAC, OECD, OIG, ointment, omitted, OncoImmune, onsite, ophthalmic, Optimmune, Organon, oropharyngeal, outpace, outreach, oxime, Padcev, PAMELA, pandemic, Pandion, papillary, Paragraph, parental, parity, Parliament, PATRICIA, PAUL, payor, Petcare, PETER, phosphate, pMMR, PN, posed, praziquantel, PRC, precision, premier, premium, PrEP, Presidentand, Presidential, proactive, processed, processing, proficient, pulse, quartile, Quebec, quickly, rank, ranking, ratified, recruiting, rectum, relebactum, representation, retention, revert, revocation, Ridgeback, RISA, ROTHMAN, Roughly, RUSSO, Salary, SAR, Schema, screening, Seagen, Seattle, SEIDMAN, Sentinel, serum, sex, shareable, sick, Silgard, simultaneously, situ, skill, spread, strict, stroke, struck, subgroup, successor, sued, supplier, systematically, Takeda, talent, talented, Taxonomy, TCA, team, temperature, temporarily, thereunto, threat, THULIN, thymic, today, topline, transgender, travel, triple, Trustee, tucatinib, Tukysa, UHC, unanimously, unchallenged, unconstitutional, undersigned, underway, unexplained, University, urgent, valuable, VelosBio, venue, Verquvo, VHL, Virbac, volunteer, volunteering, von, vulvar, WARDEN, Warranty, Week, wellbeing, WENDELL, whichever, wrongdoing, XBRL, Yervoy
Removed:
aaa, accessing, Accountant, add, adding, advancement, Alto, Alzheimer, amend, amyloid, auto, backdrop, bacteremia, bench, carboplatin, card, certiorari, cleaving, cohort, comparative, compliant, complicated, composition, Condensed, conditional, constrain, constructive, differential, discharge, discrimination, discriminatory, disparate, distinct, earliest, Ebola, eDMC, enhanced, enzyme, ERISA, eroded, escrow, expedient, expressed, expressing, extinguishment, female, hostile, Hurricane, immunity, immunization, immunology, indemnification, induce, infect, innate, insuring, intensified, intratumoral, Intron, Kelli, kill, lamivudine, legacy, loan, lone, Maria, merger, Mine, modest, Moody, noncancellable, opposed, Palo, payer, pemetrexed, Perlmutter, pledged, Poor, potent, practical, preferentially, prodromal, producer, QIDP, qualifying, read, ready, redeem, repaid, repeal, replacement, replenished, resistant, retained, retaliation, retinoic, retrospective, Rigontec, Roger, secured, Shield, significance, spanning, stop, student, suffering, suppressed, tendered, tenofovir, thereto, threatening, tradename, Unresolved, uprifosbuvir, urinary, validly, Venezuela, verubecestat, writ
Filing tables
Filing exhibits
- 10-K Annual report
- 4.10 EX-4.10 Description of Merck Common Stock
- 4.11 EX-4.11 Description of 2021 Notes, 2026 Notes, and 2034 Notes
- 4.12 EX-4.12 Description of 2024 Notes and 2036 Notes
- 10.23 EX-10.23 2021 Nqso Grant Terms Under Merck Co Inc 2019 Isp
- 10.24 EX-10.24 2021 Rsu Grant Terms Under Merck Co Inc 2019 Isp
- 21 EX-21 Subsidiary List
- 23 EX-23 Consent of Independent Registered Public Accounting Firm
- 24.1 EX-24.1 Power of Attorney
- 24.2 EX-24.2 Certification of Board Resolution
- 31.1 EX-31.1 Rule 13A-14(A)/15D-14(A) Certification of CEO
- 31.2 EX-31.2 Rule 13A-14(A)/15D-14(A) Certification of CFO
- 32.1 EX-32.1 Section 1350 Certification of CEO
- 32.2 EX-32.2 Section 1350 Certification of CFO
- Download Excel data file
- View Excel data file
Related press release
Associated MRK transcripts
MRK similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-224016 and 333-224017) and on Form S-8 (Nos. 333-173025, 333-173024, 333-162883, 333-162884, 333-162885, 333-162886, 333-121089, and 333-233226) of Merck & Co., Inc. of our report dated February 25, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Florham Park, New Jersey
February 25, 2021